+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
GLAXO

GlaxoSmithKline Pharmaceuticals Share Price

₹2,638.20 -49.4 (-1.84%)
26.34% Gain from 52W Low

18 Nov, 2026 3:54 PM (IST)

GlaxoSmithKline Pharmaceuticals live price: ₹2,638.20. It opened at ₹2,699 vs previous close ₹2,688; intraday high/low: ₹2,699/₹2,620. The 50 & 200 DMA stand at ₹2,631.70/₹2,593.90.

GlaxoSmithKline Pharmaceuticals Performance

  • Today's Low
  • ₹2,620
  • Today's High
  • ₹2,699
  • 52 Week Low
  • ₹2,088
  • 52 Week High
  • ₹3,121
  • Open Price₹2,699
  • Previous Close₹2,688
  • Volume93,286
  • 50 DMA₹2,631.70
  • 100 DMA₹2,621.30
  • 200 DMA₹2,593.90

GlaxoSmithKline Pharmaceuticals Chart

Investment Returns

  • Over 1 Month + 2.81%
  • Over 3 Month -8.31%
  • Over 6 Month + 10.39%
  • Over 1 Year + 6.04%

Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!

Invest Now

GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 39
  • PEG Ratio
  • 1.9
  • Market Cap Cr
  • 44,693
  • P/B Ratio
  • 17.8
  • Average True Range
  • 78.8
  • EPS
  • 67.7
  • Dividend Yield
  • 2.2
  • MACD Signal
  • 13.9
  • RSI
  • 52.55
  • MFI
  • 59.8

Latest Stock News Updates

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Newspaper Publication

As per attachment

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Postal Ballot Notice for approval of Related Party Transactions

GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

As per attachment

GlaxoSmithKline Pharmaceuticals Financials

GlaxoSmithKline Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2,638.20
-49.4 (-1.84%)
pointer
  • Bearish Moving Average 4
  • Bullish Moving Average 12
  • 20 Day
  • ₹2,609.40
  • 50 Day
  • ₹2,631.70
  • 100 Day
  • ₹2,621.30
  • 200 Day
  • ₹2,593.90

Resistance and Support

2652.47 Pivot Speed
  • R3 2,763.50
  • R2 2,731.30
  • R1 2,684.70
  • S1 2,605.90
  • S2 2,573.70
  • S3 2,527.10

GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-03 Quarterly Results
2026-08-03 Quarterly Results
2026-05-13 Audited Results & Dividend
2026-02-09 Quarterly Results
2025-11-06 Quarterly Results
Date Purpose Remarks
2026-05-29 FINAL Rs.57.00 per share(570%)Final Dividend
2025-05-30 FINAL Rs.42.00 per share(420%)Final Dividend
2024-11-07 INTERIM Rs.12.00 per share(120%)Interim Dividend
2024-05-31 FINAL Rs.32.00 per share(320%)Final Dividend
2023-06-30 FINAL Rs.32.00 per share(320%)Final Dividend
View GlaxoSmithKline Pharmaceuticals Dividend History Arrow

GlaxoSmithKline Pharmaceuticals Shareholding Pattern

75%
11.77%
6.07%
4.75%
2.4%

About GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals. View More
  • NSE Symbol
  • GLAXO
  • BSE Symbol
  • 500660
  • ISIN
  • INE159A01016

Similar Stocks to GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals FAQs

GlaxoSmithKline Pharmaceuticals share price is ₹2,638 As on 19 November, 2026 | 08:01

The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹44692.7 Cr As on 19 November, 2026 | 08:01

The P/E ratio of GlaxoSmithKline Pharmaceuticals is 39 As on 19 November, 2026 | 08:01

The PB ratio of GlaxoSmithKline Pharmaceuticals is 17.8 As on 19 November, 2026 | 08:01

The 52 week High & Low of GlaxoSmithKline Pharmaceuticals is ₹3120.7/₹2088.1 respectively As on 19 November, 2026 | 08:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23